reported a case of DN CTCL with clinical and pathological characteristics similar to those of primary cutaneous CD8+ CTCL, characterized by TCRβ positivity and expression of granzyme B, perforin and cytotoxic marker TIA-1 (97). This evidence concerns the gene GZMB and primary cutaneous T-cell non-Hodgkin lymphoma.